Asa Abeliovich, founder of Prevail and Alector, and now Leal Therapeutics
February 14, 2022 06:36 AM ESTUpdated 07:01 AM
People
Startups

Scoop: Star neu­ro­sci­en­tist Asa Abe­liovich and Or­biMed are team­ing on yet an­oth­er biotech

Jason Mast

Editor

It’s been bare­ly a year since Eli Lil­ly bought his sec­ond com­pa­ny, Pre­vail Ther­a­peu­tics, for $1 bil­lion, but star Co­lum­bia neu­ro­sci­en­tist Asa Abe­liovich is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times